06/23/2025
5:48 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:51 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Moran Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:32 PM | Fairmount Funds Management LLC (Filed by)
GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form SCHEDULE 13D | |
06/23/2025
5:41 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Lubner David Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:43 PM | Balcom Alexandra (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:46 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:22 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Moran Susan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:23 PM | Balcom Alexandra (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:23 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Violin Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:24 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Lubner David Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:25 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for GLYC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. |
06/23/2025
5:26 PM | Brumm Joshua T (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:27 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
McNeill Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:28 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Scalzo Richard William (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:29 PM | Doughty Christopher Grant (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:29 PM | GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Lynch Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
3:30 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G | |
06/18/2025
4:28 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
5:53 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:30 AM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
7:30 AM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
7:30 AM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
05/29/2025
7:30 AM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
05/14/2025
11:15 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form EFFECT | |
05/14/2025
4:06 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
3:39 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 424B3 | |
05/12/2025
6:12 AM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form S-4/A | |
04/28/2025
7:00 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:01 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
04/28/2025
7:17 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form S-4/A | |
04/28/2025
7:00 AM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
04/04/2025
12:29 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form S-4/A | |
04/03/2025
6:30 AM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
04/03/2025
6:30 AM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
02/28/2025
4:05 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
02/27/2025
5:01 AM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
| Form 425 | |
02/14/2025
5:38 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
8:00 AM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
8:00 AM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form DEFA14A | |
12/26/2024
3:30 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
I was wrong about Trump (Ad) I made a mistake.
A mistake I feel very foolish about.
After speaking with Donald Trump and some of his advisors, I believed him.
I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years.
But I was wrong. Let me show you exactly what we’re doing to prepare. |
11/27/2024
1:22 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G | |
11/13/2024
3:30 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
3:42 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
3:47 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form DEFA14A | |
11/06/2024
4:41 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
11/04/2024
1:01 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
Weinstein Benjamin (Filed by)
| Form SCHEDULE 13G/A | |
10/29/2024
7:09 AM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:09 AM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form DEFA14A | |
08/15/2024
4:01 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
08/09/2024
3:30 PM | DEBBANE RAYMOND (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:30 PM | DEBBANE RAYMOND (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
4:16 PM | DEBBANE RAYMOND (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
2:55 PM | GLYCOMIMETICS INC (Filer)
GlycoMimetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
6:24 PM | GLYCOMIMETICS INC (Subject)
GlycoMimetics (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
07/29/2024
4:55 PM | DEBBANE RAYMOND (Reporting)
GLYCOMIMETICS INC (Issuer)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Siren, L.L.C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
